journal article·2025-01-22Open access

Nanoparticle Contrast Agents for Dark-Field X-ray Imaging

Carlos Navarrete-León, Adam Doherty, Margarita Strimaite, Joseph C. Bear, Alessandro Olivo, Marco Endrizzi, P. Stephen Patrick

Nano Letters· Volume 25· Issue 3

Abstract

The poor soft tissue contrast of X-ray CT necessitates contrast agent use to improve diagnosis across disease applications, yet their poor detection sensitivity requires high injected doses, which restrict use in at-risk populations. Dark-field X-ray imaging is emerging as a more sensitive alternative to traditional attenuation-based imaging, leveraging scattered radiation to produce contrast. Yet aside from large, short-lived microbubbles, the alternate physics of dark-field detection has yet to be exploited for contrast agent development. Here we demonstrate that high-Z nanoparticles can provide a new means to producing dark-field image contrast, promoting scatter via a higher rather than lower electron density compared to microbubbles, increasing detection sensitivity compared to attenuation-based detection of a clinical iodine-based agent at an equivalent X-ray dose. As the use of dark-field X-ray imaging expands into more common clinical usage, this will support the development of a new class of nanoparticulate contrast agents.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Advanced X-ray Imaging Techniques · Advanced X-ray and CT Imaging · Advanced Electron Microscopy Techniques and Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Medical Physics and Biomedical Engineering, University College London, London, WC1E 6BT, United Kingdom

X-ray microscopy and tomography lab, The Francis Crick Institute, London, NW1 1AT, United Kingdom

Centre for Advanced Biomedical Imaging, Division of Medicine, University College London, London, WC1E 6DD, United Kingdom

UCL School of Pharmacy, Faculty of Life Sciences, University College London, London, WC1N 1AX, United Kingdom

School of Life Sciences, Pharmacy & Chemistry, Kingston University, Penrhyn Road, Kingston upon Thames, KT1 2EE, United Kingdom

Funding

Engineering and Physical Sciences Research Council · Medical Research Council · Royal Academy of Engineering · Diamond Light Source · Wellcome Trust

References (48)

Show source-provided references
1. 10.1038/nm157110.1038/nm1571 ↗
2. 10.1002/adma.20190653910.1002/adma.201906539 ↗
3. 10.1016/j.phrs.2016.04.02310.1016/j.phrs.2016.04.023 ↗
4. 10.1039/D0CS01075H10.1039/D0CS01075H ↗
5. 10.1126/scitranslmed.aaz225310.1126/scitranslmed.aaz2253 ↗
6. 10.1016/j.biomaterials.2020.11993010.1016/j.biomaterials.2020.119930 ↗
7. 10.1002/advs.20230624610.1002/advs.202306246 ↗
8. 10.1073/pnas.131900011110.1073/pnas.1319000111 ↗
9. 10.1016/j.jcyt.2021.02.00510.1016/j.jcyt.2021.02.005 ↗
10. 10.1038/srep3427110.1038/srep34271 ↗
11. 10.1152/physrev.00049.201010.1152/physrev.00049.2010 ↗
12. 10.1097/RLI.000000000000069610.1097/RLI.0000000000000696 ↗
13. 10.1038/srep1631810.1038/srep16318 ↗
14. 10.1186/s41747-022-00263-310.1186/s41747-022-00263-3 ↗
15. 10.1016/S2589-7500(21)00146-110.1016/S2589-7500(21)00146-1 ↗
16. 10.1021/acs.chemrev.5b0069010.1021/acs.chemrev.5b00690 ↗
17. 10.1515/plm-2011-001210.1515/plm-2011-0012 ↗
18. 10.1364/OL.50171610.1364/OL.501716 ↗
19. 10.1088/0031-9155/55/6/00810.1088/0031-9155/55/6/008 ↗
20. 10.1088/0031-9155/56/12/00410.1088/0031-9155/56/12/004 ↗
21. 10.1088/0031-9155/58/4/N3710.1088/0031-9155/58/4/N37 ↗
22. 10.1371/journal.pone.012951210.1371/journal.pone.0129512 ↗
23. 10.1186/s41747-019-0097-210.1186/s41747-019-0097-2 ↗
24. 10.1038/srep1250910.1038/srep12509 ↗
25. 10.1038/srep4668910.1038/srep46689 ↗
26. 10.1364/AO.50.00431010.1364/AO.50.004310 ↗
27. Zhang, R.; Potential use of microbubbles (MBs) as contrast material in x-ray dark field (DF) imaging: How does the DF signal change with the characteristic parameters of the MBs? Proc. SPIE 9783, Medical Imaging: Physics of Medical Imaging, 97830N (2016);10.1117/12.2216322.10.1117/12.2216322 ↗
28. 10.1088/1361-6560/ad40f510.1088/1361-6560/ad40f5 ↗
29. 10.3348/kjr.2011.12.6.71410.3348/kjr.2011.12.6.714 ↗
30. 10.1107/S160057752400503410.1107/S1600577524005034 ↗
31. 10.1080/01932691.2019.157866510.1080/01932691.2019.1578665 ↗
32. 10.1021/acsami.0c1006310.1021/acsami.0c10063 ↗
33. 10.1016/j.actbio.2018.03.02910.1016/j.actbio.2018.03.029 ↗
34. 10.1002/smll.20220640110.1002/smll.202206401 ↗
35. 10.1002/adfm.20140070610.1002/adfm.201400706 ↗
36. 10.1021/acsami.0c1095710.1021/acsami.0c10957 ↗
37. 10.1002/adma.20210631410.1002/adma.202106314 ↗
38. 10.1186/s12885-022-10310-210.1186/s12885-022-10310-2 ↗
39. 10.1038/nmat209610.1038/nmat2096 ↗
40. 10.1038/nphys26510.1038/nphys265 ↗
41. 10.1103/PhysRevLett.118.24390210.1103/PhysRevLett.118.243902 ↗
42. 10.1038/srep3094010.1038/srep30940 ↗
43. 10.1063/1.486185510.1063/1.4861855 ↗
44. 10.1038/srep3525910.1038/srep35259 ↗
45. 10.1038/s43586-021-00015-410.1038/s43586-021-00015-4 ↗
46. 10.1002/wnan.164410.1002/wnan.1644 ↗
47. 10.1002/wnan.164210.1002/wnan.1642 ↗
48. 10.1016/j.molstruc.2020.12859910.1016/j.molstruc.2020.128599 ↗